Drug Shortage Report for ACT GABAPENTIN

Last updated on 2018-10-11 History
Report ID 20300
Drug Identification Number 02256142
Brand name ACT GABAPENTIN
Common or Proper name GABAPENTIN
Company Name ACTAVIS PHARMA COMPANY
Market Status CANCELLED POST MARKET
Active Ingredient(s) GABAPENTIN
Strength(s) 100MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 500
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-08-18
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2018-10-11
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2018-10-11 French Compare
v7 2018-10-11 English Compare
v6 2018-10-11 French Compare
v5 2018-10-11 English Compare
v4 2017-10-10 French Compare
v3 2017-10-10 English Compare
v2 2017-08-24 French Compare
v1 2017-08-24 English Compare